131 related articles for article (PubMed ID: 11883935)
1. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors.
Parisi T; Pollice A; Di Cristofano A; Calabrò V; La Mantia G
Biochem Biophys Res Commun; 2002 Mar; 291(5):1138-45. PubMed ID: 11883935
[TBL] [Abstract][Full Text] [Related]
2. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
3. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
Zhang HJ; Li WJ; Yang SY; Li SY; Ni JH; Jia HT
J Cell Biochem; 2009 Feb; 106(3):464-72. PubMed ID: 19115249
[TBL] [Abstract][Full Text] [Related]
4. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2.
Gomez-Manzano C; Mitlianga P; Fueyo J; Lee HY; Hu M; Spurgers KB; Glass TL; Koul D; Liu TJ; McDonnell TJ; Yung WK
Cancer Res; 2001 Sep; 61(18):6693-7. PubMed ID: 11559537
[TBL] [Abstract][Full Text] [Related]
5. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
Won J; Yim J; Kim TK
FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
[TBL] [Abstract][Full Text] [Related]
6. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
7. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
8. ASPP1 and ASPP2 are new transcriptional targets of E2F.
Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott MJ; Dong YB; Yang H; McMasters KM
Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
[TBL] [Abstract][Full Text] [Related]
10. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
11. The E2F1-3 transcription factors are essential for cellular proliferation.
Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
[TBL] [Abstract][Full Text] [Related]
12. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
Nicolás M; Noé V; Ciudad CJ
Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F.
Montigiani S; Müller R; Kontermann RE
Oncogene; 2003 Aug; 22(32):4943-52. PubMed ID: 12902977
[TBL] [Abstract][Full Text] [Related]
17. E2F and Ras synergize in transcriptionally activating p14ARF expression.
Berkovich E; Lamed Y; Ginsberg D
Cell Cycle; 2003; 2(2):127-33. PubMed ID: 12695664
[TBL] [Abstract][Full Text] [Related]
18. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
19. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
